We are live on
!
Find out more
ACM
Atika Capital Management Portfolio holdings
AUM
$796M
1-Year Est. Return
167.57%
This Fund
S&P 500
This Quarter
Est. Return
+13.35%
1 Year Est. Return
+167.57%
3 Year Est. Return
+553.47%
5 Year Est. Return
+1,283.26%
10 Year Est. Return
+44,203.78%
AUM
$695M
AUM Growth
-$484M
(-41%)
Cap. Flow
-$523M
Cap. Flow
% of AUM
-75.27%
Top 10 Holdings %
Top 10 Hldgs %
42.72%
Holding
112
New
21
Increased
7
Reduced
35
Closed
47
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
DexCom
DXCM
|
+$15.5M |
| 2 |
Mastercard
MA
|
+$11.5M |
| 3 |
Corteva
CTVA
|
+$10.9M |
| 4 |
Tandem Diabetes Care
TNDM
|
+$9.16M |
| 5 |
SentinelOne
S
|
+$8.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Palo Alto Networks
PANW
|
+$24.1M |
| 2 |
Liberty Media Series C
FWONK
|
+$20.6M |
| 3 |
Amazon
AMZN
|
+$19.8M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$15M |
| 5 |
CrowdStrike
CRWD
|
+$14.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 36.62% |
| 2 | Technology | 31.8% |
| 3 | Communication Services | 10.64% |
| 4 | Industrials | 5.28% |
| 5 | Materials | 2.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Manchester United
MANU
$3.73B
| $9.53M | 1.37% |
+408,396
| New | +$6.83M |
|
27
BWX Technologies
BWXT
$15.6B
| $9.5M | 1.37% |
163,573
+39,203
| +32% | +$2.25M |
|
28
Coty
COTY
$2.48B
| $9.11M | 1.31% |
1,064,343
-636,862
| -37% | -$4.67M |
|
|
29
Tandem Diabetes Care
TNDM
$1.53B
| $9.09M | 1.31% |
+202,280
| New | +$9.16M |
|
30
Pool Corp
POOL
$7.5B
| $9.01M | 1.3% |
29,804
-42,196
| -59% | -$13.4M |
|
31
NVIDIA
NVDA
$5.42T
| $8.91M | 1.28% |
610,000
-90,000
| -13% | -$1.32M |
|
32
Atlanta Braves Holdings Series B
BATRK
$3.21B
| $8.32M | 1.2% |
258,061
-46,439
| -15% | -$1.45M |
|
33
Procept Biorobotics
PRCT
$1.17B
| $8.3M | 1.19% |
199,690
+78,765
| +65% | +$3.38M |
|
34
Ferguson
FERG
$49.8B
| $7.97M | 1.15% |
62,741
-34,259
| -35% | -$3.99M |
|
35
BILL Holdings
BILL
$4.78B
| $7.69M | 1.11% |
70,560
-59,440
| -46% | -$7.14M |
|
36
BioMarin Pharmaceuticals
BMRN
$12.3B
| $7.63M | 1.1% |
+73,739
| New | +$6.92M |
|
|
DEN
37
DELISTED
Denbury Inc.
DEN
| $7.44M | 1.07% |
85,500
-124,500
| -59% | -$11.3M |
|
38
Zai Lab
ZLAB
$2.62B
| $7.3M | 1.05% |
237,656
-112,344
| -32% | -$3.54M |
|
|
39
SentinelOne
S
$7.34B
| $6.88M | 0.99% |
+471,610
| New | +$8.73M |
|
40
Shoals Technologies Group
SHLS
$1.5B
| $6.78M | 0.98% |
+275,000
| New | +$6.64M |
|
|
ITCI
41
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $6.3M | 0.91% |
119,000
-44,900
| -27% | -$2.25M |
|
42
FIVE9
FIVN
$2.6B
| $5.82M | 0.84% |
+85,800
| New | +$5.39M |
|
43
Prothena Corp
PRTA
$459M
| $5.49M | 0.79% |
+91,178
| New | +$5.34M |
|
44
CALL
Pinterest
PINS
$13.4B
| $5.46M | 0.79% |
2,250
-3,200
| -59% | -$76.3K |
|
45
Jacobs Solutions
J
$17B
| $5.31M | 0.76% |
53,510
-43,208
| -45% | -$4.24M |
|
46
PUT
Citi Trends
CTRN
$605M
| $5.3M | 0.76% |
+2,000
| New | +$47.1K |
|
|
SI
47
PUT
DELISTED
Silvergate Capital Corporation
SI
| $5.06M | 0.73% |
+2,906
| New | +$115K |
|
48
Enovix
ENVX
$1.03B
| $4.95M | 0.71% |
455,006
-687,851
| -60% | -$8.46M |
|
49
Roivant Sciences
ROIV
$26.2B
| $4.47M | 0.64% |
+560,000
| New | +$3.12M |
|
|
VISN
50
CALL
Vistance Networks Inc
VISN
$2.52B
| $4.41M | 0.63% |
6,000
-14,258
| -70% | -$138K |
|
Similar funds
AGA
ACM
LSA
GWA
HP
SC
IAM
VCM
Atika Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Atika Capital Management held 112 positions worth $695M, down 41% from $1.18B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Atika Capital Management withdrew a net $523M in Q4 2022, closing 47 positions and reducing 35 holdings. Its most notable exit was Palo Alto Networks, an estimated $24.1M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 37% of assets, up from 25% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Atika Capital Management opened a new position in DexCom worth $16M.
- Atika Capital Management's largest Q4 2022 buy was DexCom: 141,635 shares worth $16M.
- Atika Capital Management added most to Clearfield in Q4 2022, an estimated $5.7M increase.
- Atika Capital Management's biggest Q4 2022 reduction was Liberty Media Series C, cutting an estimated $20.6M.
- Atika Capital Management fully exited Palo Alto Networks in Q4 2022, selling an estimated $24.1M.
- Atika Capital Management's ten largest holdings make up 43% of its $695M portfolio in Q4 2022.
- Atika Capital Management opened 21 new positions and closed 47 in Q4 2022.
- Atika Capital Management's portfolio value fell 41% quarter-over-quarter to $695M.
Based on Atika Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.